# A Study of the Effects of Posaconazole on Alectinib (RO5424802) Pharmacokinetics in Healthy Volunteers

> **NCT01984229** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 23 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Alectinib
- **DRUG:** Posaconazole

## Key facts

- **NCT ID:** NCT01984229
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2016-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01984229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01984229, "A Study of the Effects of Posaconazole on Alectinib (RO5424802) Pharmacokinetics in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01984229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*